Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCI-196 (Colestilan) in Type 2 Diabetes
NCT00497198Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing MCI-196 with Placebo (2 arms). Primary endpoints: Fasting Plasma Glucose at Baseline at 0 weeks, Change From Baseline in Blood Glucose at Week 12 and 2 more. Started Oct 2005; status: completed.
02
Drugs
colestilan
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00497198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497198.